About Us

Clinprax is a Contract Research Organization (CRO) with offices in San Jose, California and Bangalore, India, that provides clinical trial management (phase II, III and IV) and clinical trial consulting to pharmaceutical, biotechnology, and medical device companies world-wide.
Our team brings together diverse expertise and thorough understanding of the clinical and regulatory issues involved in clinical trials to meet the needs of our clients. The company leverages the advantages of clinical trials in India and technology to assist our clients deliver high quality products on time and within budget.
Our clinical trial management services include regulatory affairs, project management, medical writing, data management, site management, safety & quality monitoring for all phases of clinical trials. Our technology services include an eProject management system and electronic case report forms.
Our consulting services would provide high standard clinical trial consulting in various therapeutic areas.

Clinprax liaises between the pharmaceutical, biotechnology, and medical device companies world-wide with clinicians and health care providers and institutes to facilitate the testing of products and devices.

Clinprax’s offices and executive management in the United States allow us to be available when you need us.  Our revolutionary eProject managment system provides real time updates of clinical trial status on a dashboard accessible by you increasing transparency.  Choosing Clinprax as your CRO partner will give your study the quality and efficiency it deserves as well as the transparency so that you are always informed of the clinical trial status.

The India Advantage

Well-trained medical community to global standards. Wide spectrum of diseases with low per capita drug expenditure. Huge patient base Heterogeneous population base High enrolment rates Large and fast growing private healthcare sector State-of-the-art hospital facilities Regulatory policies facilitate clinical research. Diversity in India’s gene pool India has adequate patients and investigators India has a large number of treatment naïve patients Overall lower costs for conduct of trials. Expertise of ICH-GCP (The International conference on Harmonization – Good Clinical Practice) guidelines for conduct of clinical research English as a primary language of education and communication All investigators speak English and are GCP trained Increasingly accommodating regulatory environment Intellectual Property protection Support services such as Clinical data management Data generated in India is accepted by the FDA, major conferences and journals